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CONDENSATION 
Routine assessment of cerebroplacental ratio at 35+0 - 36+6 weeks’ gestation provides poor 
prediction of adverse perinatal outcome. 
 
AT A GLANCE 
A. To investigate the performance of screening for adverse perinatal outcome by the 
cerebroplacental ratio (CPR) measured routinely at 35+6 - 36+6 weeks’ gestation. 
 
B. In a prospective observational study in 47,211 women with singleton pregnancies 
undergoing routine ultrasound examination at 35+6 - 36+6 weeks’ gestation, low CPR 
was associated with increased risk of adverse perinatal outcome, presence of 
surrogate markers of perinatal hypoxia, cesarean section for presumed fetal distress in 
labor and birth of neonates with birthweight <3rd percentile. However, the performance 
of low CPR in the prediction of each adverse outcome was poor, with detection rates 
of 13–26% and false positive rate of about 10%.  
 
C. In pregnancies undergoing routine antenatal assessment at 35+6 - 36+6 weeks’ 
gestation measurement of CPR provides poor prediction of adverse perinatal outcome 
in both small and appropriate for gestational age fetuses. Consequently, there is no 
justification in a shift of the focus of prenatal care from identification of pregnancies 
with low estimated fetal weight to that of pregnancies with low CPR. 
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ABSTRACT 
 
Background: Third trimester studies in selected high-risk pregnancies have reported that low 
cerebroplacental ratio (CPR), due to high pulsatility index (PI) in the umbilical artery (UA), 
and or decreased PI in the fetal middle cerebral artery (MCA), is associated with increased 
risk of adverse perinatal outcomes. 
 
Objective: To investigate the predictive performance of screening for adverse perinatal 
outcome by the cerebroplacental ratio (CPR) measured routinely at 35+6 - 36+6 weeks’ 
gestation. 
 
Methods: This was a prospective observational study in 47,211 women with singleton 
pregnancies undergoing routine ultrasound examination at 35+6 - 36+6 weeks’ gestation, 
including measurement of UA-PI and MCA-PI. The measured UA-PI and MCA-PI and their 
ratio were converted to multiples of the median (MoM) after adjustment for gestational age. 
Multivariable logistic regression analysis was used to determine whether CPR improved the 
prediction of adverse perinatal outcome that was provided by maternal characteristics, 
medical history and obstetric factors. The following outcome measures were considered: 
first, adverse perinatal outcome consisting of stillbirth, neonatal death or hypoxic ischemic 
encephalopathy grades 2 and 3, second, presence of surrogate markers of perinatal hypoxia 
consisting of umbilical arterial or venous cord blood pH ≤7 and ≤7.1, respectively, 5-minute 
Apgar score <7, or admission to the neonatal intensive care unit for >24 hours, third, 
cesarean section for presumed fetal distress in labor, and fourth, neonatal birthweight <3rd 
percentile for gestational age.  
 
Results: Low CPR was associated with increased risk of adverse perinatal outcome, 
presence of surrogate markers of perinatal hypoxia, cesarean section for presumed fetal 
distress in labor and birth of neonates with birthweight <3rd percentile. However, 
multivariable regression analysis demonstrated that the prediction of these adverse 
outcomes by maternal demographic characteristics and medical history was only marginally 
improved by the addition of CPR. The performance of low CPR in the prediction of each 
adverse outcome was poor, with detection rates of 13–26% and false positive rate of about 
10%. In appropriate for gestational age (AGA) neonates with birthweight ≥10th percentile the 
predictive accuracy of CPR was low with positive and negative likelihood ratios (LRs) 
ranging from 1.21 to 1.82, and 0.92 to 0.98, respectively; although the accuracy was better 
in small for gestational age (SGA) neonates this was also low with positive LRs of 1.31 to 
2.26 and negative LRs of 0.69 to 0.92. Similar values were obtained in fetuses classified as 
SGA and AGA according to the estimated fetal weight. In the prediction of adverse outcomes 
within two weeks, rather than at any stage, after assessment the detection rate was higher 
but this was achieved at higher false positive rate and therefore similar positive and negative 
LRs. 
 
Conclusion: In pregnancies undergoing routine antenatal assessment at 35+0 - 36+6 weeks’ 
gestation measurement of CPR provides poor prediction of adverse perinatal outcome in 
both SGA and AGA fetuses. Consequently, there is no justification in a shift of the focus of 
prenatal care from identification of pregnancies with low estimated fetal weight to that of 
pregnancies with low CPR. 
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INTRODUCTION 
 
In the 1980’s studies of fetal blood obtained by cordocentesis from small for gestational age 
(SGA) fetuses demonstrated that  increased impedance to flow, reflected in high pulsatility 
index (PI) in the umbilical artery (UA), and decreased PI in the fetal middle cerebral artery 
(MCA) are associated with fetal hypoxemia and acidemia.1-4 It was subsequently shown that 
in SGA fetuses the cerebroplacental ratio (CPR) was a better predictor of adverse perinatal 
outcome than MCA-PI or UA-PI alone and that low CPR is associated with increased rates 
of perinatal death, cesarean section for fetal distress in labor, neonatal acidosis, 5 minute 
Apgar scores <7, and neonatal intensive care unit (NICU) stay >24 hours.5-8 Renewed 
interest in the CPR has be stimulated by the possibility that this index may be predictive of 
adverse perinatal outcome not only in SGA but also in appropriately grown for gestational 
age (AGA) fetuses.9-12 However, these studies have mainly examined high-risk pregnancies 
and did not report on the performance of CPR in the prediction of adverse outcome. 
 
A screening study in 30,870 women with singleton pregnancies attending for a routine 
hospital visit at 30-34 weeks’ gestation investigated the potential value of CPR in the 
prediction of adverse perinatal outcome and reported that although there was an association 
between CPR and birthweight Z-score, umbilical cord blood pH and admission to NICU, the 
performance of screening by CPR was poor with detection rates (DR) of 5-11% at false 
positive rate (FPR) of 5%.13 A possible explanation for such poor performance of screening 
was that the perinatal adverse events at term were too remote from the gestational age at 
which CPR was assessed. However, another study of 6,178 singleton pregnancies routinely 
screened at 35-37 weeks’ gestation, also reported significant associations between CPR and 
indicators of adverse perinatal outcome but again the performance of screening by CPR was 
poor with DR of 6-15%, at FPR of 6%.14  
 
The objective of this extended study of 47,211 singleton pregnancies undergoing routine 
screening at 35+6 – 36+6 weeks’ gestation is to investigate further the potential value of CPR 
in the prediction of adverse perinatal outcome.  
 
METHODS 
 
Study population 
 
This was a prospective study in women with singleton pregnancies attending for a routine 
hospital visit at 35+0 - 36+6 weeks’ gestation at King’s College Hospital, London or Medway 
Maritime Hospital, Gillingham, UK between March 2014 and September 2018. This visit 
included recording of maternal demographic characteristics and medical history, ultrasound 
examination for fetal anatomy and measurement of fetal head circumference, abdominal 
circumference and femur length for calculation of EFW15,16 and transabdominal color Doppler 
ultrasound for measurement of the UA-PI and MCA-PI.17 Gestational age was determined by 
the measurement of fetal crown-rump length at 11-13 weeks.18  
 
The women gave written informed consent to participate in the study, which was approved 
by the National Health Service Research Ethics Committee. The inclusion criteria for this 
study were singleton pregnancies examined at 35+0 - 36+6 weeks’ gestation and delivering a 
non-malformed live birth or stillbirth. We excluded pregnancies with aneuploidies and major 
fetal abnormalities. Data from the first 6,178 pregnancies included in this study were 
reported previously.14  
 
Patient characteristics  
 
Patient characteristics recorded included maternal age, racial origin (White, Black, South 
Asian, East Asian and mixed), method of conception (spontaneous or assisted by use of 
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ovulation induction drugs or in vitro fertilization), cigarette smoking during pregnancy, 
medical history of chronic hypertension or diabetes mellitus, obstetric history (nulliparous if 
no previous pregnancies at ≥24 weeks and parous with or without previous history of 
preeclampsia (PE) and / or birth of SGA neonate with birthweight <10th percentile) and 
presence of obstetric cholestasis or gestational diabetes mellitus in the current pregnancy. 
Maternal weight and height were measured and body mass index (BMI) was calculated. 
 
Outcome measures 
 
Data on pregnancy outcome were collected from the hospital maternity records. The 
following prespecified outcome measures were considered: first, adverse perinatal outcome 
consisting of stillbirth, neonatal death or hypoxic ischemic encephalopathy grades 2 and 3, 
second, presence of surrogate markers of perinatal hypoxia consisting of umbilical arterial or 
venous cord blood pH ≤7 and ≤7.1, respectively, 5-minute Apgar score <7, or admission to 
NICU for >24 hours, third, cesarean section for presumed fetal distress in labor, and fourth, 
SGA neonates with birthweight <3rd percentile.16 Cesarean section for presumed fetal 
distress in labor was carried out if there was evidence of a pathological electronic fetal heart 
rate pattern, a STAN event on fetal electrocardiogram analysis or fetal scalp pH <7.1. 
Hypoxic-ischemic encephalopathy was diagnosed when there was disturbed neurologic 
function with evidence of perinatal hypoxia reflected in either a 5-minute Apgar score <5 or 
umbilical artery cord pH <7.0 or base deficit >12 mmol/L, supported by neuroimaging 
evidence of acute brain injury. 
 
Statistical analysis 
 
Data were expressed as median (interquartile range [IQR]) for continuous variables and n 
(%) for categorical variables. Mann-Whitney U-test and χ2-square test or Fisher’s exact test, 
were used for comparing outcome groups for continuous and categorical data, respectively. 
Significance was assumed at 5%. 
 
Univariable and multivariable logistic regression analysis was carried out to determine which 
of the factors from maternal or pregnancy characteristics and measurements of UA-PI and 
MCA-PI and their ratio, provided a significant contribution in the prediction of each of the four 
outcome measures. Prior to the regression analysis, the continuous variables, such as age, 
weight and height were centred by subtracting the arithmetic mean from each value to avoid 
effects of multicollinearity. Multiple categorical variables were dummy coded as binary 
variables to estimate the independent effect of each category. The measured UA-PI and 
MCA-PI and their ratio were converted to multiples of the median (MoM) after adjustment for 
gestational age.17 The birth weight Z-score was derived from the Fetal Medicine Foundation 
fetal and neonatal population weight charts.16 We estimated cut-offs for the 90th percentile 
for UA-PI and 10th percentiles for MCA-PI and CPR and determined the prevalence of 
abnormal Doppler values in each of the outcome groups. The values of UA-PI >90th 
percentile, MCA-PI <10th percentile and CPR <10th percentile were used as binary 
categorical variables in the multivariable regression analysis for each outcome measure. 
Predicted probabilities from logistic regression analysis were used to construct receiver 
operating characteristic (ROC) curves to assess performance of screening for these adverse 
outcomes. The area under ROC (AUROC) curves for fetal Doppler alone was compared to 
that obtained from all factors.17 We examined the DR, FPR and positive and negative 
likelihood ratios (LR) of CPR <10th percentile for adverse perinatal outcome, presence of 
surrogate markers of perinatal hypoxia and cesarean section for presumed fetal distress in 
labor in the sub-groups of SGA (birthweight <10th percentile) and AGA (birthweight ≥10th 
percentile) fetuses and neonates born within two weeks and at any stage after assessment. 
 
The statistical package SPSS 24.0 (IBM SPSS Statistics for Windows, Version 24.0, 
Armonk, NY: IBM Corp; 2016) was used for data analyses. 
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RESULTS 
 
Study population 
 
During the study period, we prospectively examined and measured MCA-PI and UA-PI in 
47,521 singleton pregnancies. We excluded 268 (0.6%) for major fetal abnormalities or 
genetic syndromes diagnosed prenatally or postnatally and 42 (0.1%) for no follow-up. The 
study population comprised 47,211 pregnancies. The median interval between assessment 
at 35+6 – 36+6 weeks’ gestation and delivery was 3.7 (IQR 2.9, 4.7) weeks. 
 
Adverse perinatal outcome 
 
Adverse perinal outcome occurred in 130 (0.3%) cases and included 53 stillbirths, 11 
neonatal deaths and 66 cases of HIE grades 2 or 3. The maternal and pregnancy 
characteristics of those with and without adverse perinal outcome are compared in Table 1. 
In pregnancies with adverse perinatal outcome there was a higher median maternal weight 
and BMI, higher incidence of nulliparous women, lower incidence of parous women without 
previous SGA or PE, and lower median MoM values for MCA-PI and CPR. 
 
Multivariable regression analysis demonstrated that in prediction of adverse perinal outcome 
there was a statistically significant contribution from maternal BMI, nulliparity, MCA-PI and 
CPR <10th percentile (R2=0.021; p<0.001; Table 2 and S1). The performance of screening 
by maternal factors alone in prediction of adverse perinatal outcome (DR 17.7% at FPR of 
10%) was significantly improved by the addition of MCA and CPR (DR 26.2% at FPR of 
10%; AUROC: 607, 95% CI 0.603, 0.612 vs. 0.644, 95% CI 0.639, 0.648; p=0.041) (Figure 
1).  
 
Surrogate markers of perinatal hypoxia 
 
The 47,081 pregnancies without adverse perinatal outcome, included 1,370 (2.9%) with and 
45,711 without surrogate markers of perinatal hypoxia. The maternal and pregnancy 
characteristics of these two groups are compared in Table S2. In pregnancies with surrogate 
markers of perinatal hypoxia there was a lower median maternal age, height, MCA-PI MoM, 
CPR MoM and birthweight, a lower incidence of women from East Asian and mixed racial 
origin, higher median maternal weight and BMI and higher incidence of cigarette smokers, 
women from Black racial origin, nulliparous women, those with diabetes mellitus, obstetric 
cholestasis, and birthweight <10th percentile. 
 
Multivariable regression analysis demonstrated that in prediction of pregnancies with 
surrogate markers of perinatal hypoxia there was a statistically significant contribution from 
maternal BMI, cigarette smoking, Black and mixed racial origin, nulliparity, obstetric 
cholestasis, MCA-PI and CPR <10th percentile (R2=0.021; p<0.001; Table 2 and S3). The 
performance of screening by maternal factors alone in prediction of adverse neonatal 
outcome (DR 17.2% at FPR of 10%) was significantly improved by the addition of MCA and 
CPR (DR 18.7% at FPR of 10%; AUROC: 0.588, 95% CI 0.583, 0.592 vs. 0.595, 95% CI 
0.590, 0.599; p=0.032) (Figure 1).  
 
Cesarean section for presumed fetal distress 
 
The 47,158 pregnancies with livebirths, included 34,834 with vaginal delivery following 
spontaneous or induced labor, 5,475 with elective cesarean section for a variety of 
indications and 6,653 with cesarean section following spontaneous or induced labor; in the 
latter group, the indication for cesarean section was presumed fetal distress in 2,590 cases 
(Figure 2). Among those who underwent elective cesarean section (n=5,671) there were a 
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variety of indications including breech or transverse lie, placenta previa, previous cesarean 
section or traumatic birth, maternal medical disorder or maternal request (n=5,475) and fetal 
compromise diagnosed by abnormal Doppler findings or fetal-heart rate patterns in SGA 
fetuses (n=196). 
 
The maternal and pregnancy characteristics of those delivering by cesarean section for 
presumed fetal distress in labor are compared to those with vaginal delivery in Table S4. In 
pregnancies delivering by cesarean section for presumed fetal distress there was a lower 
median height, MCA-PI MoM, CPR MoM and birthweight, higher median maternal age, 
weight, BMI and UA-PI MoM and higher incidence of women of Black and South Asian racial 
origin, those who conceived by in vitro fertilisation, nulliparous women and parous women 
with a previous history of SGA or PE, chronic hypertension, diabetes mellitus, gestational 
diabetes, EFW <10th percentile and birthweight <10th percentile.  
 
Multivariable regression analysis demonstrated that in prediction of cesarean section for 
presumed fetal distress in labor, there was a statistically significant contribution from 
maternal age, BMI, cigarette smoking, Black and South Asian racial origin, conception by in 
vitro fertilization nulliparity, previous PE or SGA, chronic hypertension, diabetes mellitus, 
EFW <10th percentile, and CPR <10th percentile (R2=0.087; p<0.0001; Table 2 and S5). In 
screening for cesarean section for presumed fetal distress by maternal factors alone the DR 
was 29.5% at FPR of 10%; addition of CPR did not improve the performance of screening 
(AUROC: 0.705, 95% CI 0.694, 0.705 vs. 0.706, 95% CI 0.695, 0.716; p=0.222) (Figure 1).  
 
In SGA neonates delivered by elective cesarean section for presumed fetal distress, the 
performance of screening by maternal factors, obstetric and medical history (DR 85.2%, 
FPR 10%) was improved by the addition of UA-PI, MCA-PI and CPR (DR 91.8%, FPR 10%; 
AUROC: 0.896, 95% CI 0.868, 0.923 vs. 0.971, 95% CI 0.961, 0.981; p<0.0001). The CRP 
was <10th percentile in 67.9% (133/196) of cases with cesarean section for presumed fetal 
distress and in 9.5% (3307/34834) of those with vaginal delivery. 
 
SGA neonates with birthweight <3rd percentile 
 
The study population of 47,211 pregnancies included 2,102 (4.5%) with birthweight <3rd 
percentile and 45,109 (95.5%) with birthweight ≥3rd percentile. The maternal and pregnancy 
characteristics of those with and without SGA <3rd are compared in Table S6. In pregnancies 
with SGA <3rd percentile there was a lower median maternal age, weight, height, BMI, MCA-
PI MoM, CPR MoM, and birthweight, lower incidence of women with diabetes mellitus, 
higher median UA-PI MoM and higher incidence of women of Black, South Asian and mixed 
racial origin, those who conceived by in vitro fertilisation, nulliparous women and those 
parous women with a previous history of SGA or PE, chronic hypertension, EFW <10th 
percentile and birthweight <10th percentile. The CRP was <10th percentile in 25.9% of cases 
with birthweight <3rd percentile and in 9.1% of those with birthweight ≥3rd percentile. 
 
Multivariable regression analysis demonstrated that in prediction of SGA <3rd there was a 
statistically significant contribution from maternal age, BMI, Black, South Asian and mixed 
racial origin, cigarette smoking, diabetes mellitus, parity, UA-PI >90th percentile, MCA-PI 
<10th percentile and CPR <10th percentile (R2=0.335; p=0.001; Table 2 and S7). The 
performance of screening by maternal factors and EFW alone in prediction of SGA <3rd (DR 
68.7% at FPR of 10%) was improved by the addition of UA, MCA and CPR (DR 69.7% at 
FPR of 10%; AUROC: 858, 95% CI 849, 867 vs. 0.865, 95% CI 0.856, 0.874; p<0.0001) 
(Figure 1).  
 
Performance of screening in pregnancies with SGA and AGA fetuses or neonates 
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There was a significant association between log10MoM CPR and birthweight Z-score 
(r=0.210, P<0.0001). The incidence of CPR <10th percentile increased with decreasing 
birthweight percentile; the incidence was 20.9% for birthweight <10th percentile, 12.3% 
between the 10th and 25th percentiles, 9.8% between the 25th and 50th percentiles, 7.6% 
between the 50th and 75th percentiles, 6.0% between the 75th and 90th percentiles and 5.3%  
for birthweight >90th percentile. 
 
The incidence of adverse perinatal outcome was 0.4% (20/5,509) in babies with birthweight 
<10th percentile and 0.3% (110/41,702) in those with birthweight ≥10th percentile (p=0.186). 
Consequently, 84.6% (110/130) of adverse perinatal outcome occurred in AGA babies. The 
CRP was <10th percentile in 20.0% of cases with and in 9.8% of those without adverse 
perinatal outcome. The incidence of surrogate markers of perinatal hypoxia was 4.2% 
(230/5,489) in babies with birthweight <10th percentile and in 2.7% (1,140/41,592) of those 
with birthweight ≥10th percentile (p<0.0001). Consequently, 83.3% (1,141/1,370) of adverse 
perinatal outcome occurred in AGA babies. The CRP was <10th percentile in 13.7% of cases 
with and in 9.7% of those without surrogate markers of perinatal hypoxia. The incidence of 
cesarean section for presumed fetal distress in labor was 11.1% (503/4,543) in babies with 
birthweight <10th percentile and in 6.3% (2,087/32,881) with birthweight ≥10th percentile 
(p<0.0001). Consequently, 80.6% (2,087/2,590) of cesarean section for presumed fetal 
distress occurred in AGA babies. The CRP was <10th percentile in 13.1% of cases with 
cesarean section for presumed fetal distress and in 9.5% of those with vaginal delivery.  
 
The DR, FPR positive LR and negative LR of CPR <10th percentile in the prediction of 
adverse perinatal outcome, perinatal hypoxia, cesarean section for presumed fetal distress 
in pregnancies with SGA and AGA fetuses and neonates are shown in Table 3. In AGA 
neonates the predictive accuracy of CPR was low with positive and negative LRs ranging 
from 1.21 to 1.82, and 0.92 to 0.98, respectively; although the accuracy was better in SGA 
neonates this was also low with positive LRs of 1.31 to 2.26 and negative LRs of 0.69 to 
0.92. Similar values were obtained in fetuses classified as SGA and AGA according to the 
estimated fetal weight. In the prediction of adverse outcomes within two weeks, rather than 
at any stage, after assessment the DR was higher but this was achieved at higher FPR and 
therefore similar positive and negative LRs. 
 
COMMENT 
 
Principal findings of the study 
 
The findings of this study of routine ultrasound examination in singleton pregnancies at 35+0-
36+6 weeks’ gestation demonstrate that although the incidence of adverse perinatal 
outcome, presence surrogate markers of perinatal hypoxia and cesarean section for 
presumed fetal distress in labor is higher in pregnancies with SGA compared to AGA 
fetuses; 80-85% of these adverse events occur in the AGA group. If it was to be assumed 
that first, these adverse outcomes are the consequence of impaired placentation and fetal 
hypoxia and second, low CPR is a good marker of fetal hypoxia irrespective of fetal size, it 
should be anticipated that low CPR would be a good predictor of adverse outcome. It could 
then be argued that prenatal care should be directed at identifying hypoxemic rather than 
small fetuses and, consequently, screening should focus on the detection of pregnancies 
with low CPR rather than those with low estimated fetal weight. 
 
We found that low CPR was associated with increased risk of adverse perinatal outcome, 
presence of surrogate markers of perinatal hypoxia, cesarean section for presumed fetal 
distress in labor and birth of neonates with birthweight <3rd percentile. However, 
multivariable regression analysis demonstrated that the prediction of these adverse 
outcomes by maternal demographic characteristics and medical history was only marginally 
improved by the addition of CPR. The performance of low CPR in the prediction of each 
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adverse outcome was poor, with DR of 13–26% and FPR of about 10%. The DR of adverse 
outcomes was higher in SGA than in AGA babies, irrespective of whether the classification 
was based on estimated fetal weight or birthweight and in pregnancies delivering within two 
weeks rather than at any stage after assessment. However, such increase in DR was 
accompanied by an increase in FPR and the predictive accuracy of the test was low, 
reflected in low positive LRs and high negative LRs irrespective of fetal size or interval 
between testing and delivery. 
 
The low performance of CPR in the prediction of adverse perinatal outcomes suggests that 
either CPR provides poor assessment of fetal oxygenation or that first, most cases of 
stillbirth at term are not associated with impaired placentation and chronic fetal hypoxia and 
second, the contribution of maternal and pregnancy characteristics as well as events in labor 
play a much greater role than prelabor fetal oxygenation in the development of fetal distress 
in labor or adverse neonatal outcome. 
 
Strengths and limitations of the study 
 
The strengths of our study are first, examination of a large number of pregnancies, including 
5,509 that delivered SGA neonates, attending for routine assessment of fetal growth and 
wellbeing at a prespecified gestational-age range at the end of the third trimester of 
pregnancy, second, measurement of MCA-PI and UA-PI by appropriately-trained doctors, 
and third, use of a wide range of well accepted indicators for adverse perinatal outcome.  
 
The main limitation of this and most previous studies investigating the value of CPR in the 
prediction of adverse pregnancy outcome is that the results of the ultrasound scan were 
made available to the attending obstetricians who would have taken specific actions of 
further monitoring and planned delivery of the cases with suspected SGA and fetal 
compromize. In our study 196 such pregnancies had elective delivery by cesarean section; 
had this not been carried out it is possible that some of the cases would have resulted in 
stillbirth, cesarean section for fetal distress in labor and birth asphyxia. Consequently, the 
performance of screening by CPR for adverse perinatal outcome in SGA fetuses would have 
been negatively biased. 
 
Comparison with findings from previous studies 
 
Several prospective and retrospective studies in small numbers of third trimester high-risk 
pregnancies reported an association between low CPR or low MCA-PI and increased risk of 
adverse perinatal outcomes, but they did not report on the predictive performance of the 
test.7  
 
Our study, in 47,211 pregnancies, evaluated CPR at 35+0 - 36+6 weeks’ gestation as part of 
routine screening for adverse perinatal outcome in all pregnant women, irrespective of fetal 
size or interval from delivery. Our findings confirm the association between low CPR and 
adverse perinatal outcomes but demonstrate that the predictive performance of the test in 
both SGA and AGA fetuses is poor. These findings are consisted with those of our previous 
study in 30,870 pregnancies undergoing routine screening at 30-34 weeks’ gestation.13  
 
Implications for clinical practice 
 
About 85% of SGA neonates are born at term,20 and in such neonates the risk of adverse 
outcome is substantially higher than in AGA neonates.21,22 The traditional approach of 
identifying pregnancies with SGA fetuses is maternal abdominal palpation and serial 
measurements of symphysial-fundal height, which is advocated by national guidelines in the 
USA and many other developed countries; however, the predictive performance of such 
screening is poor.23-25 There is some evidence that substantially improved prediction of SGA 
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is achieved by universal sonographic fetal biometry during the third trimester, especially at 
about 36 weeks’ gestation.20,26-30 A prospective study in 19,208 singleton pregnancies 
undergoing routine antenatal assessment at 35+0 - 36+6 weeks’ gestation reported that a 
combination of maternal demographic characteristics and medical history with 
sonographically estimated fetal weight predicted 90% of SGA neonates delivering within two 
weeks and at any stage after assessment at respective screen positive rates of about 20% 
and 30%.20  
 
In this study we found that in pregnancies undergoing such routine antenatal assessment at 
35+0 - 36+6 weeks measurement of CPR provides poor prediction of adverse perinatal 
outcome in both SGA and AGA fetuses. Consequently, there is no justification for a shift of 
the focus of prenatal care from identification of pregnancies with low estimated fetal weight 
to that of pregnancies with low CPR. There is no evidence that incorporating CPR in the 
management of AGA fetuses reduces perinatal death or other adverse perinatal outcomes, 
but there is a risk that such practice would increase early iatrogenic delivery.  
 
There is also lack of evidence that incorporating CPR in the management of SGA fetuses 
reduces perinatal death or other adverse perinatal outcomes. This raises the question as to 
the best management of pregnancies at high risk of delivering SGA neonates; specifically, 
30% of the population identified by combined screening with maternal factors and fetal 
biometry at 35+0 - 36+6 weeks’ gestation to contain 90% of SGA neonates.20 On the basis of 
results from observational studies measurement of CPR can contribute in the differentiation 
of constitutionally-small from growth-restricted fetuses.8,30 It could then be argued that in the 
subgroup of the 30% of the population at high risk of delivering SGA neonates those with 
CPR <10th percentile should undergo iatrogenic delivery at around 37 weeks, whereas those 
with CPR ≥10th percentile could have close surveillance with delayed delivery until 39-40 
weeks. The extent to which such policy would reduce adverse perinatal outcome merits 
further investigation.  
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Figure legend 
 
Figure 1. Receiver operating characteristic plots of screening for adverse perinal outcome 
(a), surrogate markers of perinatal hypoxia (b), cesarean section for presumed fetal distress 
in labor (c), elective cesarean section for presumed fetal distress in small for gestational age 
fetuses (d) and birthweight <3rd percentile (e) by maternal factors (black curve) and the 
combination of maternal factors and Doppler findings (red curve). 
 
Figure 2. Flow chart on the indications and method of delivery of the study population.  
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Table 1. Maternal and pregnancy characteristics in pregnancies with and without adverse 
perinal outcome. 
 
 
 
IQR = interquartile range; SGA = small for gestational age with birthweight <10
th
 percentile; PE = 
preeclampsia; PI = pulsatility index; MoM = multiple of the median 
 
Significance value * p<0.05; ** p<0.01 
 
  
Maternal and pregnancy characteristics 
No adverse outcome 
(n=47,081) 
Adverse outcome 
(n=130) 
Maternal age in years, median (IQR) 31.6 (27.3-35.4) 31.1 (27.3-34.9) 
Maternal weight in kg, median (IQR) 79.0 (70.8-90.0) 83.0 (73.4-92.0)* 
Maternal height in cm, median (IQR) 165 (160-169) 165 (161-169) 
Maternal body mass index in kg/m
2
, median (IQR) 29.1 (26.2-32.9) 29.7 (27.3-34.5)* 
Cigarette smoker, n (%) 3,840 (8.2) 11 (8.5) 
Racial origin   
     White, n (%) 34,994 (74.3) 92 (70.8) 
     Black, n (%) 7,461 (15.8) 28 (21.5) 
     South Asian, n (%) 2,250 (4.8) 4 (3.1) 
     East Asian, n (%) 966 (2.1) 2 (1.5) 
     Mixed, n (%) 1,410 (3.0) 4 (3.1) 
Conception   
     Natural, n (%) 45,465 (96.6) 127 (97.7) 
     Use of ovulation induction drugs, n (%)  264 (0.6) 0 
     In vitro fertilization, n (%) 1,352 (2.9) 3 (2.3) 
Obstetric history   
     Nulliparous, n (%) 21,389 (45.4) 76 (58.5)** 
     Parous, previous SGA or PE, n (%) 4,216 (9.0) 6 (4.6) 
     Parous, no previous SGA or PE , n (%) 21,476 (45.6) 48 (36.9)* 
Medical disorders   
     Chronic hypertension, n (%) 595 (1.3) 1 (0.8) 
     Diabetes mellitus, n (%) 381 (0.8) 0 
Pregnancy complications   
     Gestational diabetes, n (%) 2029 (4.3) 4 (3.1) 
     Obstetric cholestasis, n (%) 496 (1.1) 2 (1.5) 
Doppler indices   
     Umbilical artery PI in MoM, median (IQR) 1.01 (0.91-1.11) 1.01 (0.91-1.10) 
     Umbilical artery PI >90
th
 percentile, n (%) 4,090 (8.7) 10 (7.7) 
     Middle cerebral artery PI in MoM, median (IQR) 1.00 (0.90-1.10) 0.95 (0.85-1.06)** 
     Middle cerebral artery PI <10
th
 percentile, n (%) 3,984 (8.5) 25 (19.2)** 
     Cerebroplacental ratio in MoM, median (IQR) 0.99 (0.87-1.13) 0.96 (0.80-1.13)* 
     Cerebroplacental ratio <10
th
 percentile, n (%) 4,614 (9.8) 26 (20.0)** 
          Stillbirth (n=53) - 13 (24.5) 
          Neonatal death (n=11) - 2 (18.2) 
          Hypoxic ischemic encephalopathy (n=66) - 11 (16.7) 
Estimated weight <10
th
 percentile, n (%) 4,276 (9.1) 6 (4.6) 
GA at delivery in weeks, median (IQR) 40.0 (39.0-40.9) 39.8 (38.7-41.0) 
Birth weight in g, median (IQR) 3,420 (3100-3470) 3,360 (3075-3765) 
Birth weight <10
th
 percentile, n (%) 5,489 (11.7) 20 (15.4) 
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Table 2. Multivariable logistic regression analysis in prediction of adverse perinatal outcome, surrogate markers of perinatal hypoxia, cesarean 
section for fetal distress in labor and birthweight <3rd percentile  from maternal and pregnancy characteristics. 
 
OR = odds ratio; CI = confidence interval; BMI = body mass index; SGA = small for gestational age with birthweight <10
th
 percentile; PE = preeclampsia; PI = 
pulsatility index; MoM = multiple of the median. 
Maternal and pregnancy characteristics 
Adverse perinatal outcome Perinatal hypoxia CS for fetal distress Birthweight <3
rd percentile 
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value 
Maternal age – 30 (years)     1.04 (1.03-1.04) <0.0001 1.02 (1.01-1.03) <0.0001 
Maternal BMI – 30 (kg/m
2
) 1.05 (1.02-1.08) <0.0001 1.04 (1.03-1.05) <0.0001 1.07 (1.06-1.08) <0.0001 0.98 (0.97-0.99) 0.001 
Cigarette smoker   1.41 (1.19-1.68) <0.0001 1.40 (1.20-1.63) <0.0001 2.38 (2.05-2.76) <0.0001 
Racial origin         
     Black   1.17 (1.02-1.35) 0.029 1.90 (1.71-2.10) <0.0001 2.04 (1.79-2.32) <0.0001 
     South Asian     1.57 (1.32-1.87) <0.0001 2.27 (1.90-2.71) <0.0001 
     Mixed   0.61 (0.41-0.90) 0.014   1.72 (1.32-2.24) <0.0001 
Conception         
     In vitro fertilization     1.34 (1.08-1.67) 0.009   
Obstetric history         
     Nulliparous 1.71 (1.20-2.43) 0.003 1.42 (1.28-1.58) <0.0001 3.92 (3.54-4.33) <0.0001 2.34 (2.08-2.64) <0.0001 
     Parous, previous PE or SGA     1.51 (1.27-1.80) <0.0001 2.54 (2.18-2.97) <0.0001 
Medical complications         
     Chronic hypertension     1.52 (1.13-2.06) 0.007   
     Diabetes mellitus     1.70 (1.14-2.54) 0.010 0.44 (0.21-0.94) 0.033 
Pregnancy complications         
     Gestational diabetes         
    Cholestasis   1.68 (1.12-2.53) 0.012     
Estimated fetal weight <10
th
 percentile     1.25 (1.09-1.43) 0.001 20.02 (18.07-22.19) <0.0001 
Doppler indices         
    UA-PI >90
th
 percentile       1.67 (1.44-1.94) <0.0001 
    MCA-PI <10
th
 percentile 1.97 (1.20-3.23) 0.007 1.26 (1.05-1.50) 0.014   1.58 (1.35-1.85) <0.0001 
    CPR <10
th
 percentile 1.71 (1.05-2.79) 0.031 1.36 (1.15-1.61) <0.0001 1.31 (1.16-1.48) <0.0001 1.67 (1.43-1.95) <0.0001 
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Table 3. Predictive performance of cerebroplacental ratio <10th percentile for adverse perinatal outcome, surrogate markers of perinatal 
hypoxia and cesarean section for fetal distress in labor in small and appropriate for gestational age fetuses and neonates 
 
Classification according to estimated fetal weight 
Cerebroplacental ratio <10th percentile 
At any stage after assessment Within two weeks of assessment 
Weight ≥10
th
 percentile Weight <10
th
 percentile Weight ≥10
th
 percentile Weight <10
th
 percentile 
Adverse perinatal outcome (n=130)     
  Detection rate 23/124 (18.5; 11.8, 25.2) 3/6 (50.0; 41.4, 58.6) 6/23 (26.1; 8.9, 43.3) 1/1  
  False positive rate 3,790/42,805 (8.9; 8.6, 9.2) 824/4,276 (19.3; 18.9, 19.7) 612/4,896 (12.5; 11.6, 13.4) 437/1,296 (33.7; 32.4, 35.0) 
  Positive likelihood ratio  2.08 (1.94, 2.22) 2.59 (2.44, 2.74) 2.09 (1.69, 2.49) 2.97 (2.49, 3.45) 
  Negative likelihood ratio 0.89 (0.80, 0.98) 0.62 (0.54, 0.70) 0.84 (0.58, 1.10) 0.00 
Perinatal hypoxia (n=1,370)     
  Detection rate 131/1,223 (10.7; 9.1, 12.3) 57/147 (38.8; 36.2, 41.4) 49/258 (19.0; 14.2, 23.8) 42/73 (57.5; 46.3, 68.6) 
  False positive rate 3,659/41,582 (8.8; 8.5, 9.1) 767/4,129 (18.6; 18.2, 19.0) 563/4,638 (12.0; 11.0, 12.9) 395/1,223 (32.3; 29.7, 34.9) 
  Positive likelihood ratio  1.22 (1.12, 1.32) 2.09 (1.95, 2.23) 1.58 (1.22, 1.94) 1.78 (1.04, 2.52) 
  Negative likelihood ratio 0.98 (0.89, 1.00) 0.75 (0.67, 0.83) 0.92 (0.65, 1.19) 0.63 (0.19, 1.07) 
Cesarean section for fetal distress (n=2,590)     
  Detection rate 261/2,296 (11.4; 10.2, 12.6) 79/294 (26.9; 25.2, 28.6) 51/213 (23.9; 18.2, 29.6) 55/121 (45.5; 36.6, 54.4) 
  False positive rate 2,751/31,576 (8.7; 8.4, 9.0) 556/3,258 (17.1; 16.7, 17.5) 393/3,320 (11.8; 10.7, 12.9) 253/861 (29.4; 26.4, 32.4) 
  Positive likelihood ratio  1.31 (1.20, 1.42) 1.57 (1.45, 1.69) 2.03 (1.55, 2.51) 1.55 (0.72, 2.38) 
  Negative likelihood ratio 0.97 (0.88, 1.00) 0.88 (0.79, 0.97) 0.86 (0.55, 1.17) 0.77 (0.19, 1.35) 
Classification according to birthweight      
Adverse perinatal outcome (n=130)     
  Detection rate 17/110 (15.5; 9.3, 21.74) 9/20 (45.0; 36.5, 53.6) 4/19 (21.0; 14.0, 28.1) 3/5 (60.0; 51.6, 68.4) 
  False positive rate 3,523/41,592 (8.5; 8.2, 8.8) 1,091/5,489 (19.9; 19.5, 20.3) 575/4,781 (12.0; 11.7, 12.3) 474/1,411 (33.6; 32.2, 35.1) 
  Positive likelihood ratio  1.82 (1.69, 1.95) 2.26 (2.51, 2.81) 1.75 (1.38, 2.12) 1.79 (1.10, 2.48) 
  Negative likelihood ratio 0.92 (0.83, 1.00) 0.69 (0.61, 0.77) 0.90 (0.63, 1.17) 0.60 (0.20, 1.00) 
Perinatal hypoxia (n=1,370)     
  Detection rate 116/1140 (10.2; 8.6, 11.8) 72/230 (31.3; 28.8, 33.8) 42/241 (17.4; 15.1, 19.8) 49/90 (54.4; 48.8, 60.0) 
  False positive rate 3,407/40,452 (8.4; 8.1, 8.7) 1,019/5,259 (19.4; 19.0, 19.8) 533/4,540 (11.7; 11.4, 12.0) 425/1,321 (32.2; 30.8, 33.7) 
  Positive likelihood ratio  1.21 (1.11, 1.31) 1.61 (1.49, 1.73) 1.49 (1.14, 1.84) 1.69 (1.00, 2.39) 
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  Negative likelihood ratio 0.98 (0.89, 1.00) 0.85 (0.76, 0.94) 0.94 (0.66, 1.22) 0.67 (0.23, 1.11) 
Cesarean section for fetal distress (n=2,590)     
  Detection rate 220/2,087 (10.5; 9.3, 11.7) 120/503 (23.9; 22.3, 25.5) 45/206 (21.8; 20.0, 23.6) 61/128 (47.7; 43.3, 52.1) 
  False positive rate 2,573/30,794 (8.4; 8.0, 8.7) 734/4,040 (18.2; 17.8, 18.6) 368/3,250 (11.3; 11.0, 11.6) 278/931 (29.9; 28.5, 31.3) 
  Positive likelihood ratio  1.25 (1.14, 1.36) 1.31 (1.20, 1.42) 1.93 (1.36, 2.50) 1.60 (0.92, 2.28) 
  Negative likelihood ratio 0.98 (0.89, 1.00) 0.92 (0.83, 1.00) 0.88 (0.49, 1.27) 0.75 (0.28, 1.22) 
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Table S1. Univariable and multivariable logistic regression analysis in prediction of adverse 
perinatal outcome from maternal and pregnancy characteristics. 
 
 
BMI = body mass index; OR = odds ratio; CI = confidence interval; SGA = small for gestational age 
with birthweight <10
th
 percentile; PE = preeclampsia; PI = pulsatility index; MoM = multiple of the 
median. 
 
  
Maternal and pregnancy 
characteristics 
Univariate analysis Multivariate analysis 
OR (95% CI) P value OR (95% CI) P value 
Maternal age – 30 (years) 0.99 (0.96-1.02) 0.536   
Maternal BMI – 30 (kg/m
2
) 1.05 (1.02-1.07) 0.002 1.05 (1.02-1.08) <0.0001 
Cigarette smoker 1.04 (0.56-1.93) 0.899   
Racial origin     
     White 1.00 (Reference)    
     Black 1.43 (0.93-2.18) 0.100   
     South Asian 0.68 (0.25-1.84) 0.44   
     East Asian 0.79 (0.19-3.20) 0.738   
     Mixed 1.08 (0.40-3.94) 0.882   
Conception     
     Natural 1.00 (Reference)    
     Use of ovulation induction drugs - -   
     In vitro fertilization 0.79 (0.25-2.50) 0.694   
Obstetric history     
     Parous, no previous PE or SGA 1.00 (Reference)    
     Nulliparous 1.59 (1.11-2.28) 0.012 1.71 (1.20-2.43) 0.003 
     Parous, previous PE or SGA 0.64 (0.27-1.49) 0.298   
Pregnancy complications     
     Gestational diabetes 0.71 (0.26-1.91) 0.492   
     Cholestasis 1.47 (0.36-5.95) 0.591   
Estimated fetal weight     
     Z-score 1.07 (0.91-1.26) 0.427   
     <10
th
 percentile 0.48 (0.21-1.10) 0.083   
Doppler indices     
    UA-PI >90
th
 percentile 0.88 (0.46-1.67) 0.688   
    MCA-PI <10
th
 percentile 2.58 (1.66-3.99) <0.001 1.97 (1.20-3.23) 0.007 
    CPR <10
th
 percentile 2.30 (1.50-3.54) <0.001 1.71 (1.05-2.79) 0.031 
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Table S2. Maternal and pregnancy characteristics in pregnancies with and without surrogate 
markers of perinatal hypoxia.  
 
 
IQR = interquartile range; SGA = small for gestational age with birthweight <10
th
 percentile; PE = 
preeclampsia; PI = pulsatility index; MoM = multiple of the median 
 
Significance value * p<0.05; ** p<0.01 
 
Maternal and pregnancy characteristics 
No surrogate markers 
(n=45,711) 
Surrogate markers 
(n=1,370) 
Maternal age in years, median (IQR) 31.6 (27.0-35.4) 30.9 (26.5-35.1)** 
Maternal weight in kg, median (IQR) 79.0 (70.7-90.0) 81.0 (72.0-93.3)** 
Maternal height in cm, median (IQR) 165 (160-169) 164 (160-168)** 
Maternal body mass index in kg/m
2
, median (IQR) 29.1 (26.2-32.9) 30.1 (26.9-34.7)** 
Cigarette smoker, n (%) 3692 (8.1) 148 (10.8)** 
Racial origin   
     White, n (%) 33974 (74.3) 1020 (74.5) 
     Black, n (%) 7213 (15.8) 248 (18.1)* 
     South Asian, n (%) 2191 (4.8) 59 (4.3) 
     East Asian, n (%) 949 (2.1) 17 (1.2)* 
     Mixed, n (%) 1384 (3.0) 26 (1.9)* 
Conception   
     Natural, n (%) 44147 (96.6) 1318 (96.2) 
     Use of ovulation induction drugs, n (%)  256 (0.6) 8 (0.6) 
     In vitro fertilization, n (%) 1308 (2.9) 44 (3.2) 
Obstetric history   
     Nulliparous, n (%) 20680 (45.2) 709 (51.8)** 
     Parous, previous SGA or PE, n (%) 4087 (8.9) 125 (9.1) 
     Parous, no previous SGA or PE , n (%) 20944 (45.8) 536 (39.1) 
Medical disorders   
     Chronic hypertension, n (%) 570 (1.2) 25 (1.8) 
     Diabetes mellitus, n (%) 360 (0.8) 22 (1.6)** 
Pregnancy complications   
     Gestational diabetes, n (%) 1960 (4.3) 68 (5.0) 
     Obstetric cholestasis, n (%) 471 (1.0) 25 (1.8)** 
Doppler indices   
     Umbilical artery PI in MoM, median (IQR) 1.01 (0.91-1.11) 1.02 (0.91-1.12) 
     Umbilical artery PI >90
th
 percentile, n (%) 3951 (8.6) 141 (10.3) 
     Middle cerebral artery PI in MoM, median (IQR) 1.00 (0.90-1.10) 0.99 (0.89-1.09)** 
     Middle cerebral artery PI <10
th
 percentile, n (%) 3831 (8.4) 153 (11.2)** 
     Cerebroplacental ratio in MoM, median (IQR) 0.99 (0.87-1.13) 0.99 (0.87-1.13)** 
     Cerebroplacental ratio <10
th
 percentile, n (%) 4426 (9.7) 188 (13.7)** 
Estimated weight <10
th
 percentile, n (%) 4129 (9.0) 147 (10.7) 
GA at delivery in weeks, median (IQR) 40.0 (39.0-40.9) 39.8 (38.3-40.9)** 
Birth weight in g, median (IQR) 3420 (3105-3740) 3380 (3000-3755)** 
Birth weight <10
th
 percentile, n (%) 5259 (11.5) 229 (16.7)** 
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Table S3. Univariable and multivariable logistic regression analysis in prediction of surrogate 
markers of perinatal hypoxia from maternal and pregnancy characteristics. 
 
 
BMI = body mass index; OR = odds ratio; CI = confidence interval; SGA = small for gestational age 
with birthweight <10
th
 percentile; PE = preeclampsia; PI = pulsatility index; MoM = multiple of the 
median. 
  
Maternal and pregnancy 
characteristics 
Univariate analysis Multivariate analysis 
OR (95% CI) P value OR (95% CI) P value 
Maternal age – 30 (years) 0.99 (0.98-1.00) 0.004   
Maternal BMI – 30 (kg/m
2
) 1.04 (1.03-1.05) <0.0001 1.04 (1.03-1.05) <0.0001 
Cigarette smoker 1.36 (1.14-1.61) <0.0001 1.41 (1.19-1.68) <0.0001 
Racial origin     
     White 1.00 (Reference)    
     Black 1.14 (0.99-1.31) 0.067 1.17 (1.02-1.35) 0.029 
     South Asian 0.88 (0.68-1.15) 0.348   
     East Asian 0.60 (0.38-0.96) 0.034   
     Mixed 0.60(0.40-0.88) 0.010 0.61 (0.41-0.90) 0.014 
Conception     
     Natural 1.00 (Reference)    
     Use of ovulation induction drugs 1.00 (0.49-2.02) 0.995   
     In vitro fertilization 1.10 (0.81-1.49) 0.543   
Obstetric history     
     Parous, no previous PE or SGA 1.00 (Reference)    
     Nulliparous 1.39 (1.24-1.55) <0.0001 1.42 (1.28-1.58) <0.0001 
     Parous, previous PE or SGA 1.20 (0.99-1.46) 0.069   
Medical complications     
     Chronic hypertension 1.40 (0.94-2.10) 0.100   
     Diabetes mellitus 1.87 (1.20-2.91) 0.006   
Pregnancy complications     
     Gestational diabetes 1.14 (0.90-1.46) 0.281   
     Cholestasis 1.70 (1.13-2.55) 0.010 1.68 (1.12-2.53) 0.012 
Estimated fetal weight     
     Z-score 1.02 (0.97-1.07) 0.566   
     <10
th
 percentile 1.16 (0.97-1.38) 0.098   
Doppler indices     
    UA-PI >90
th
 percentile 1.16 (0.97-1.38) 0.099   
    MCA-PI <10
th
 percentile 1.45 (1.23-1.71) <0.0001 1.26 (1.05-1.50) 0.014 
    CPR <10
th
 percentile 1.50 (1.29-1.75) <0.0001 1.36 (1.15-1.61) <0.0001 
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Table S4. Maternal and pregnancy characteristics in pregnancies delivering by cesarean 
section for fetal distress in labor compared to those that delivered vaginally. 
 
 
 
IQR = interquartile range; SGA = small for gestational age with birthweight <10
th
 percentile; PE = 
preeclampsia; PI = pulsatility index; MoM = multiple of the median 
 
Significance value * p<0.05; ** p<0.01 
 
 
  
Maternal and pregnancy characteristics 
Vaginal delivery 
(n=34,834) 
Cesarean section 
(n=2,590) 
Maternal age in years, median (IQR) 31.1 (26.8-34.9) 31.4 (27.1-35.3)* 
Maternal weight in kg, median (IQR) 78.3 (70.0-89.0) 81.0 (72.0-92.2)** 
Maternal height in cm, median (IQR) 165 (161-170) 163 (159-167)** 
Maternal body mass index in kg/m
2
, median (IQR) 28.7 (25.9-32.3) 36.7 (27.4-34.4)** 
Cigarette smoker, n (%) 2983 (8.6) 223 (8.6) 
Racial origin   
     White, n (%) 26216 (75.3) 1703 (65.8) 
     Black, n (%) 5213 (15.0) 597 (23.1)** 
     South Asian, n (%) 1612 (4.6) 160 (6.2)** 
     East Asian, n (%) 725 (2.1) 47 (1.8) 
     Mixed, n (%) 1068 (3.1) 83 (3.2) 
Conception   
     Natural, n (%) 33908 (97.3) 2469 (95.3) 
     Use of ovulation induction drugs, n (%)  177 (0.5) 17 (0.7) 
     In vitro fertilization, n (%) 749 (2.2) 104 (4.0)** 
Obstetric history   
     Nulliparous, n (%) 15464 (44.4) 1800 (69.5)** 
     Parous, previous SGA or PE, n (%) 3040 (8.7) 184 (7.1)** 
     Parous, no previous SGA or PE , n (%) 16330 (46.9) 606 (23.4) 
Medical disorders   
     Chronic hypertension, n (%) 328 (0.9) 55 (2.1)** 
     Diabetes mellitus, n (%) 189 (0.5) 30 (1.2)** 
Pregnancy complications   
     Gestational diabetes, n (%) 1208 (3.5) 128 (4.9)** 
     Obstetric cholestasis, n (%) 359 (1.0) 36 (1.4) 
Doppler indices   
     Umbilical artery PI in MoM, median (IQR) 1.01 (0.91-1.11) 1.02 (0.91-1.13)* 
     Umbilical artery PI >90
th
 percentile, n (%) 2975 (8.5) 257 (9.9)* 
     Middle cerebral artery PI in MoM, median (IQR) 1.00 (0.90-1.10) 0.98 (0.89-1.08)** 
     Middle cerebral artery PI <10
th
 percentile, n (%) 2822 (8.1) 270 (10.4)** 
     Cerebroplacental ratio in MoM, median (IQR) 0.99 (0.87-1.13) 0.97 (0.85-1.08)** 
     Cerebroplacental ratio <10
th
 percentile, n (%) 3307 (9.5) 340 (13.1)** 
Estimated weight <10
th
 percentile, n (%) 3258 (9.4) 294 (11.4)** 
GA at delivery in weeks, median (IQR) 40.1 (39.1-40.9) 40.4 (39.3-41.3)** 
Birth weight in g, median (IQR) 3420 (3105-3730) 3350 (3000-3700)** 
Birth weight <10
th
 percentile, n (%) 4040 (11.6) 503 (19.4)** 
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Table S5. Univariable and multivariable logistic regression analysis in prediction of cesarean 
section from fetal distress from maternal and pregnancy characteristics. 
 
 
BMI = body mass index; OR = odds ratio; CI = confidence interval; SGA = small for gestational age 
with birthweight <10
th
 percentile; PE = preeclampsia; PI = pulsatility index; MoM = multiple of the 
median. 
 
  
Maternal and pregnancy characteristics 
Univariate analysis Multivariate analysis 
OR (95% CI) P value OR (95% CI) P value 
Maternal age – 30 (years) 1.01 (1.00-1.02) 0.007 1.04 (1.03-1.04) <0.0001 
Maternal BMI – 30 (kg/m
2
) 1.06 (1.05-1.07) <0.0001 1.07 (1.06-1.08) <0.0001 
Cigarette smoker 1.01 (0.87-1.16) 0.935 1.40 (1.20-1.63) <0.0001 
Racial origin     
     White 1.00 (Reference)    
     Black 1.76 (1.60-1.94) <0.0001 1.90 (1.71-2.10) <0.0001 
     South Asian 1.53 (1.29-1.81) <0.0001 1.57 (1.32-1.87) <0.0001 
     East Asian 1.00 (0.74-1.35) 0.989   
     Mixed 1.20 (0.95-1.50) 0.124   
Conception     
     Natural 1.00 (Reference)    
     Use of ovulation induction drugs 1.32 (0.80-2.17) 0.277   
     In vitro fertilization 1.91 (1.55-2.35) <0.0001 1.34 (1.08-1.67) 0.009 
Obstetric history     
     Parous, no previous PE or SGA 1.00 (Reference)    
     Nulliparous 3.14 (2.85-3.45) <0.0001 3.92 (3.54-4.33) <0.0001 
     Parous, previous PE or SGA 1.63 (1.38-1.93) <0.0001 1.51 (1.27-1.80) <0.0001 
Medical complications     
     Chronic hypertension 2.82 (1.71-3.05) <0.0001 1.52 (1.13-2.06) 0.007 
     Diabetes mellitus 2.15 (1.46-3.16) <0.0001 1.70 (1.14-2.54) 0.010 
Pregnancy complications     
     Gestational diabetes 1.45 (1.20-1.74) <0.0001   
     Cholestasis 1.35 (0.96-1.91) 0.085   
Estimated fetal weight     
     Z-score 1.02 (0.98-1.06) 0.394   
     <10
th
 percentile 1.24 (1.09-1.41) 0.001 1.25 (1.09-1.43) 0.001 
Doppler indices     
    UA-PI >90
th
 percentile 1.18 (1.03-1.35) 0.016   
    MCA-PI <10
th
 percentile 1.32 (1.16-1.51) <0.0001   
    CPR <10
th
 percentile 1.44 (1.28-1.62) <0.0001 1.31 (1.16-1.48) <0.0001 
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Table S6. Maternal and pregnancy characteristics in pregnancies delivering small for 
gestational age neonates with birthweight <3rd percentile compared to those with birthweight 
≥3rd percentile. 
 
 
 
IQR = interquartile range; SGA = small for gestational age with birthweight <10
th
 percentile; PE = 
preeclampsia; PI = pulsatility index; MoM = multiple of the median 
 
Significance value * p<0.05; ** p<0.01 
 
 
  
Maternal and pregnancy characteristics 
Birthweight ≥3rd  
(n=45,109) 
Birthweight <3
rd
 
(n=2,102) 
Maternal age in years, median (IQR) 31.6 (27.3-35.4) 31.0 (26.1-35.1)** 
Maternal weight in kg, median (IQR) 79.0 (71.0-90.0) 73.0 (65.0-83.0)** 
Maternal height in cm, median (IQR) 165 (161-169) 162 (158-167)** 
Maternal body mass index in kg/m
2
, median (IQR) 29.2 (26.2-33.0) 27.7 (24.8-31.5)** 
Cigarette smoker, n (%) 3480 (7.7) 371 (17.6)** 
Racial origin   
     White, n (%) 33795 (74.9) 1291 (61.4)** 
     Black, n (%) 7036 (15.6) 453 (21.6)** 
     South Asian, n (%) 2029 (4.5) 225 (10.7)** 
     East Asian, n (%) 917 (2.0) 51 (2.4) 
     Mixed, n (%) 1332 (3.0) 82 (3.9)* 
Conception   
     Natural, n (%) 43579 (96.6) 2013 (95.8) 
     Use of ovulation induction drugs, n (%)  252 (0.6) 12 (0.6) 
     In vitro fertilization, n (%) 1278 (2.8) 77 (3.7)* 
Obstetric history   
     Nulliparous, n (%) 20272 (44.9) 1193 (56.8)** 
     Parous, previous SGA or PE, n (%) 3798 (8.4) 4245 (20.2)** 
     Parous, no previous SGA or PE , n (%) 21039 (46.6) 485 (23.1) 
Medical disorders   
     Chronic hypertension, n (%) 560 (1.2) 36 (1.7)* 
     Diabetes mellitus, n (%) 372 (0.8) 9 (0.4)* 
Pregnancy complications   
     Gestational diabetes, n (%) 1936 (4.3) 97 (4.6) 
     Obstetric cholestasis, n (%) 483 (1.1) 15 (0.7) 
Doppler indices   
     Umbilical artery PI in MoM, median (IQR) 1.01 (0.91-1.11) 1.10 (0.99-1.20)** 
     Umbilical artery PI >90
th
 percentile, n (%) 3627 (8.0) 473 (22.5)** 
     Middle cerebral artery PI in MoM, median (IQR) 1.00 (0.90-1.10) 0.95 (0.86-1.04)** 
     Middle cerebral artery PI <10
th
 percentile, n (%) 3649 (8.1) 360 (17.1)** 
     Cerebroplacental ratio in MoM, median (IQR) 1.00 (0.89-1.13) 0.88 (0.77-1.01)** 
     Cerebroplacental ratio <10
th
 percentile, n (%) 4095 (9.1) 545 (25.9)** 
Estimated weight <10
th
 percentile, n (%) 2927 (6.5) 1355 (64.5) 
GA at delivery in weeks, median (IQR) 40.0 (39.0-40.9) 39.0 (37.9-40.0)** 
Birth weight in g, median (IQR) 3450 (3150-3760) 2490 (23  00-2635)** 
Birth weight <10
th
 percentile, n (%) 3407 (7.6) 2102 (100.0)** 
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Table S7. Univariable and multivariable logistic regression analysis in prediction of 
pregnancies delivering small for gestational age neonates with birthweight <3rd percentile 
from maternal and pregnancy characteristics. 
 
 
BMI = body mass index; OR = odds ratio; CI = confidence interval; SGA = small for gestational age 
with birthweight <10
th
 percentile; PE = preeclampsia; PI = pulsatility index; MoM = multiple of the 
median. 
 
 
 
Maternal and pregnancy 
characteristics 
Univariate analysis Multivariate analysis 
OR (95% CI) P value OR (95% CI) P value 
Maternal age – 30 (years) 0.98 (0.97-0.99) <0.0001 1.02 (1.01-1.03) <0.0001 
Maternal BMI – 30 (kg/m
2
) 0.94 (0.93-0.95) <0.0001 0.98 (0.97-0.99) 0.001 
Cigarette smoker 2.56 (2.28-2.88) <0.0001 2.38 (2.05-2.76) <0.0001 
Racial origin     
     White 1.00 (Reference)    
     Black 1.69 (1.51-1.88) <0.0001 2.04 (1.79-2.32) <0.0001 
     South Asian 2.90 (2.50-3.36) <0.0001 2.27 (1.90-2.71) <0.0001 
     East Asian 1.46 (1.09-1.94) 0.010   
     Mixed 1.61 (1.28-2.03) <0.0001 1.72 (1.32-2.24) <0.0001 
Conception     
     Natural 1.00 (Reference)    
     Use of ovulation induction drugs 1.03 (0.58-1.84) 0.918   
     In vitro fertilization 1.30 (1.03-1.65) 0.026   
Obstetric history     
     Parous, no previous PE or SGA 1.00 (Reference)    
     Nulliparous 2.55 (2.29-2.84) <0.0001 2.34 (2.08-2.64) <0.0001 
     Parous, previous PE or SGA 4.84 (4.23-5.54) <0.0001 2.54 (2.18-2.97) <0.0001 
Medical complications     
     Chronic hypertension 1.39 (0.99-1.95) 0.060   
     Diabetes mellitus 0.52 (0.27-1.00) 0.051 0.44 (0.21-0.94) 0.033 
Pregnancy complications     
     Gestational diabetes 1.08 (0.88-1.33) 0.476   
     Cholestasis 0.66 (0.39-1.11) 0.120   
Estimated fetal weight     
     Z-score 0.15 (0.14-0.16) <0.0001   
     <10
th
 percentile 26.14 (23.72-28.8) <0.0001 20.02 (18.07-22.19) <0.0001 
Doppler indices     
    UA-PI >90
th
 percentile 3.32 (2.98-3.69) <0.0001 1.67 (1.44-1.94) <0.0001 
    MCA-PI <10
th
 percentile 2.35 (2.09-2.64) <0.0001 1.58 (1.35-1.85) <0.0001 
    CPR <10
th
 percentile 3.51 (3.16-3.89) <0.0001 1.67 (1.43-1.95) <0.0001 
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Total population n=47,211  
Live birth  n=47,158  
Stillbirth             n = 53  
Labor  n=47,158  
Elective cesarean section 
- SGA and fetal distress    n = 196 
- Other indications            n = 5,475  
Cesarean section 
- Presumed fetal distress n = 2,590 
- Other indications            n = 4,063  
Vaginal delivery n=34,834  
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